)
PTC Therapeutics (PTCT) investor relations material
PTC Therapeutics 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Key business achievements and financial performance
Achieved $334 million annualized revenue run rate by Q3, with 100% year-over-year growth and GAAP profitability.
Maintained 70% gross margins despite subscale ASPs and underutilized lab capacity.
Delivered $153 million in GAAP revenue in 2024, exceeding projections, and guided 2025 revenue to $293–$299 million, with 2026 guidance raised to $415–$430 million.
Achieved profitability with only 10% of the accumulated deficits of public competitors.
Projected continued GAAP operating margin positivity for 2025 and 2026.
Technology and product innovation
Developed a patented single molecule next-generation sequencing platform enabling 10x better sensitivity and precision.
QCT technology allows for single molecule-level sensitivity, reducing noise and improving accuracy in cfDNA testing.
Unity prenatal test directly identifies fetal risk from maternal blood, detecting three times as many affected pregnancies as traditional methods.
Oncology products Northstar Select and Northstar Response offer 50%+ more actionable variant detection and earlier therapy response monitoring.
Technology enables both tumor-naive and tissue-free MRD testing, with plans to expand into early cancer detection.
Market strategy and growth drivers
Rapidly expanding test volume, with 51% year-over-year growth and increasing in-network coverage to over 250 million contracted lives.
Sales force is smaller than competitors but highly productive, adding 100 new clinics per quarter.
ASPs have surpassed $500 per test, with further growth expected from coding, contracting, and coverage improvements.
Oncology segment expected to grow faster than prenatal due to lower base and strong early indicators.
Guidance for 2026 does not depend on a specific sales rep headcount, but ongoing expansion is planned.
Next PTC Therapeutics earnings date
Next PTC Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)